Stefan Scheding (@stemstef) / Twitter
AcouSort »2022 | AcouSort applies for listing on Nasdaq First North Growth Market | AcouSort
Join Spotlight | Spotlight
Xintela - Advancing integrins as innovation engine | Edison
AddLifes CEO: “I look up to Investor”
Stefan Scheding (@stemstef) / Twitter
IPO-guiden hissar en flagga inför Spotlights notering | Affärsvärlden
Is COVID-19 a Perfect Storm for Parkinson's Disease?: Trends in Neurosciences
Acousort har idag sista handelsdag på Spotlight före byte till First North
Sortera in Acousort bland de bättre förhoppningsbolagen | Peter Benson | SvD
Blog - Page 4 of 12 - exRNA Portal
RXinsider | Controlled Substance Ordering (CSOS) Software
Lots of Movement in Gut and Parkinson's Research - ScienceDirect
ACOU- 2019-03-21 - YouTube
Stefan Scheding (@stemstef) / Twitter
2021 BioBuzz Awards Finalists · BioBuzz
AcouSort is looking for new team members! | Medicon Village
Börsprat (@borsprat) / Twitter
Spotlight sätter ljuset på småbolagens dilemma | Affärsvärlden
Analyst Group (@Analyst_Group) / Twitter
AcouSort - Analyst Group
Xintela - Advancing integrins as innovation engine | Edison
Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let's talk about the lipids in the room | npj Parkinson's Disease
2018 Top 10 Innovations | The Scientist Magazine®
